<DOC>
	<DOC>NCT02476318</DOC>
	<brief_summary>A prospective, multi-center study to evaluate the safety and performance outcomes of the ArterX Vascular Sealant when used for prophylactic sealing of suture lines at the anastomosis between native vessel and synthetic vascular grafts.</brief_summary>
	<brief_title>A Study to Evaluate the Safety and Performance of ArterX™ Vascular Sealant in Sealing Synthetic Arterial Grafts</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>1. The subject must be ≥ 18 years old 2. The subject must be scheduled for surgical placement of a synthetic graft for large vessel repair/ arterial reconstruction/ hemodialysis access. 3. The subject has no child bearing potential or has a negative serum or urine pregnancy test within 7 days of the index procedure. 4. The subject is willing and able to be contacted for minimum of 6 weeks follow up. 5. The subject or guardian must provide written informed consent using a form that is reviewed and approved by the Ethics Committee. 1. The subject has a known hypersensitivity or contraindication to heparin, bovine or seafood products. 2. The subject has a history of bleeding diathesis or coagulopathy, or will refuse blood transfusion. 3. The subject is currently enrolled in this, or another investigational device or drug trail that has not completed the required followup period. 4. ArterX Vascular Sealant should not be used in patients who have exhibited an allergic reaction to materials of shellfish or bovine origin.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>